Tabular list notes for D75.839
The tabular list has no notes on D75.839 itself; the notes below apply from its parent headings.
Inherited from D75 (Other and unspecified diseases of blood and blood-forming organs)
- Excludes2 (not part of this condition, may be coded together)
- acute lymphadenitis (L04.-)
- chronic lymphadenitis (I88.1)
- enlarged lymph nodes (R59.-)
- hypergammaglobulinemia NOS (D89.2)
- lymphadenitis NOS (I88.9)
- mesenteric lymphadenitis (acute) (chronic) (I88.0)
Inherited from D75.83 (Thrombocytosis)
- Excludes2 (not part of this condition, may be coded together)
- essential thrombocythemia (D47.3)
MS-DRG grouping when D75.839 is the principal diagnosis
The final group also depends on procedures, secondary diagnoses and discharge status; the MS-DRG lookup for D75.839 shows the full grouping logic.
CC/MCC status and inpatient edits
D75.839 is neither a CC nor an MCC under MS-DRG v44, so as a secondary diagnosis it does not raise the MS-DRG severity level. Check D75.839 against a principal diagnosis.
- Present on admission: a POA indicator is required on inpatient claims.
CMS-HCC V28 risk adjustment
D75.839 does not map to a payment HCC in the PY2027 CMS-HCC V28 model, so on its own it does not change a Medicare Advantage risk score.
LCD billing and coding articles that list D75.839
9 current Medicare billing and coding articles list D75.839 among the diagnoses that support medical necessity for the services they cover.
- Billing and Coding: Erythropoiesis Stimulating Agents (ESAs) A56795
- Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies A57837
- Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies A57873
- Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies A57878
- Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies A57891
- Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms A59827
- Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms A59835
- Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms A59919
For teams evaluating QuickIntell software
Evaluate software for diagnosis coding review
If your team codes diagnoses at volume, review how QuickCode supports qualified coder review of documentation, specificity queries and the billing handoff. Confirm the code sets, settings and reviewer responsibilities during evaluation; a code reference is not a coding determination for a patient.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
What does ICD-10-CM D75.839 mean?
D75.839 means thrombocytosis, unspecified. It is one of 13 billable codes under D75, other and unspecified diseases of blood and blood-forming organs.
Which MS-DRG does D75.839 group to?
As the principal diagnosis, D75.839 groups to MS-DRG 814 Reticuloendothelial and Immunity Disorders with MCC, MS-DRG 815 Reticuloendothelial and Immunity Disorders with CC, MS-DRG 816 Reticuloendothelial and Immunity Disorders without CC/MCC (MDC 16 MDC 16: Diseases and Disorders of Blood, Blood Forming Organs and Immunologic Disorders) under MS-DRG v44, before procedures and secondary diagnoses are applied.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-10. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- ICD-10-CM FY2027 tabular order file (category titles)Version FY2027 · effective 2026-10-01 · file icd10cm_order_2027.txtSHA-256 38981fb2c1226e2b…
- ICD-10-CM FY2027 tabular list (chapter titles and ranges)Version FY2027 · effective 2026-10-01 · file 2027-code-tables-tabular-index.zipSHA-256 37baa476323714be…
- ICD-10-CM FY2027 code descriptions addenda (codes added, deleted and revised)Version FY2027 · effective 2026-10-01 · file icd10cm_codes_addenda_2027.txtSHA-256 cfba025073235af4…
- ICD-10 MS-DRG Definitions Manual v44 (text)Version v44 · effective 2026-10-01 · file fy2027-fr-icd10-ms-drg-definitions-manual-files-v44.zipSHA-256 ae4f6c11727fe91f…
- IPPS FY2027 Tables 6A-6K: new, invalid and revised ICD-10-CM/PCS codes, CC/MCC list changes and CC exclusionsVersion FY2027 (final rule; not reissued by CN3) · effective 2026-10-01 · file fy2027-ipps-fr-tables-6a-6k.zipSHA-256 ca0af87b0869a405…
- ICD-10-CM FY2027 POA-exempt codes (full list, additions, deletions and revisions)Version FY2027 · effective 2026-10-01 · file 2027-poa-exempt-codes.zipSHA-256 03f55091045024d0…
- ICD-10-CM to CMS-HCC V28 mappings, payment year 2027 initialVersion PY2027 initial ICD-10-CM mappings (dates of service 2026) · effective 2027-01-01 · file 2027 Initial ICD-10-CM Mappings.csvSHA-256 9c260b06d0dd2806…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-10-08 · effective 2026-10-04 · file article.csvSHA-256 5e95c4a8ac3664be…
Disclaimer
The descriptor and notes are reproduced from the FY2027 ICD-10-CM files; MS-DRG, CC/MCC and HCC facts come from the CMS FY2027 and PY2027 tables. Code from the medical record and the ICD-10-CM Official Guidelines. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.